Koushik K. Das

Koushik K. Das

Auto-generated profile, based on publicly available information

Koushik K. Das

Division of Gastroenterology, Washington University School of Medicine, St Louis, Missouri, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
KDKoushik K. Das
Koushik K. Das
XGXin Geng
Xin Geng
JBJeffrey Wade Brown
Jeffrey Wade Brown
VMVicente Morales-Oyarvide
Vicente Morales-Oyarvide
THTiffany Huynh
Tiffany Huynh
MMMari Mino-Kenudson
Mari Mino-Kenudson

19 October 2023 in npj Precision Oncology
Verified
Journal Article
Open access
PDF file
ESErik P. Storrs
Erik P. Storrs
PCPrathamesh Chati
Prathamesh Chati
AUAbul Usmani
Abul Usmani
ISIan Sloan
Ian Sloan
BKBradley A. Krasnick
Bradley A. Krasnick
ACAadel A. Chaudhuri
Aadel A. Chaudhuri
Numerous cell states are known to comprise the pancreatic ductal adenocarcinoma (PDAC) tumor microenvironment (TME). However, the developmental stemness and co-occurrence of these cell states remain poorly defined. Here, we performed single-cell RNA sequencing (scRNA-seq) on a cohort of treatment-naive PDAC time-of-diagnosis endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) samples (n = 25). We then combined these samples with surgical resection (n = 6) and publicly available samples to increase statistical power (n = 80). Following annotation into 25 distinct cell states, cells were scored for developmental stemness, and a customized version of the Ecotyper tool was used to identify communities of co-occurring cell states in bulk RNA-seq samples (n = 268). We discovered a tumor microenvironmental community comprised of aggressive basal-like malignant cells, tumor-promoting SPP1+ macrophages, and myofibroblastic cancer-associated fibroblasts associated with especially poor prognosis. We also found a developmental stemness continuum with implications for survival that is present in both malignant cells and cancer-associated fibroblasts (CAFs). We further demonstrated that high-dimensional analyses predictive of survival are feasible using standard-of-care, time-of-diagnosis EUS-FNB specimens. In summary, we identified tumor microenvironmental and developmental stemness characteristics from a high-dimensional gene expression analysis of PDAC using human tissue specimens, including time-of-diagnosis EUS-FNB samples. These reveal new connections between tumor microenvironmental composition, CAF and malignant cell stemness, and patient survival that could lead to better upfront risk stratification and more personalized upfront clinical decision-making.

1 December 2021 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
KDKoushik K. Das
Koushik K. Das
SHStephen Hasak
Stephen Hasak
SESherif Elhanafi
Sherif Elhanafi
KVKavel H. Visrodia
Kavel H. Visrodia
GGGregory G. Ginsberg
Gregory G. Ginsberg
VCVinay Chandrasekhara
Vinay Chandrasekhara

1 May 2021 in Human Pathology
Verified
Journal Article
Closed access
KDKoushik K. Das
Koushik K. Das
JBJeffrey Wade Brown
Jeffrey Wade Brown
CDCarlos Fernandez Del-Castillo
Carlos Fernandez Del-Castillo
THTiffany Huynh
Tiffany Huynh
JMJason C. Mills
Jason C. Mills
MMMari Mino-Kenudson
Mari Mino-Kenudson

6 September 2017 in Current Treatment Options in Gastroenterology
Verified
Journal Article
Closed access
PDF file
KDKoushik K. Das
Koushik K. Das
DEDayna Early
Dayna Early

14 February 2023 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
KDKoushik K. Das
Koushik K. Das
JBJeffrey Wade Brown
Jeffrey Wade Brown
Metaplasia, dysplasia, and cancer arise from normal epithelia via a plastic cellular transformation, typically in the setting of chronic inflammation. Such transformations are the focus of numerous studies that strive to identify the changes in RNA/Protein expression that drive such plasticity along with the contributions from the mesenchyme and immune cells. However, despite being widely utilized clinically as biomarkers for such transitions, the role of glycosylation epitopes is understudied in this context. Here, we explore 3′-Sulfo-Lewis A/C, a clinically validated biomarker for high-risk metaplasia and cancer throughout the gastrointestinal foregut: esophagus, stomach, and pancreas. We discuss the clinical correlation of sulfomucin expression with metaplastic and oncogenic transformation, as well as its synthesis, intracellular and extracellular receptors and suggest potential roles for 3′-Sulfo-Lewis A/C in contributing to and maintaining these malignant cellular transformations.